Product image of Wilate (Human Coagulation Factor Viii, Human Von Willebrand Factor) supplied by GNH India

Wilate

Active Ingredient:
Human Coagulation Factor Viii, Human Von Willebrand Factor
Origin:
EU

Wilate (Human Coagulation Factor Viii, Human Von Willebrand Factor)

Wilate is a human coagulation factor VIII and von Willebrand factor concentrate used for bleeding disorder management. This intravenous therapy supports hemostasis in conditions like von Willebrand disease. Suitable for patients requiring factor replacement.

Manufacturer / TM Owner

Octapharma (Ip) Sprl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Wilate is used to treat and prevent bleeding episodes in patients with von Willebrand disease or hemophilia A. It works by replacing missing or deficient clotting factors in the blood. This helps the blood clot normally, reducing the risk of excessive bleeding. It may also be used before medical procedures to prevent bleeding.

Side Effects

  • After administration, Wilate helps restore normal clotting function in the bloodstream. Patients may experience improved bleeding control within hours of infusion. The duration of effect varies depending on individual response and the condition being treated. Regular use may help maintain steady clotting factor levels.

Precautions & Warnings

  • Wilate should be handled with care to avoid contamination or improper administration. Patients with known allergies to human blood products should use this medication cautiously. Always follow healthcare provider instructions for storage and use. Report any unusual symptoms or reactions immediately.

Avoid Interactions

  • Wilate may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Combining Wilate with these medications could alter their effects. Always inform your healthcare provider about all medications you are taking. Alcohol and certain dietary supplements may also interact.

Frequently Asked Questions

Wilate is used to treat and prevent bleeding in patients with von Willebrand disease or hemophilia A by replacing missing clotting factors.

Wilate is given as an intravenous infusion, typically by a healthcare professional in a clinical setting.

Wilate is a prescription medication and should only be obtained through licensed pharmacies or healthcare providers.

Common side effects may include headache, nausea, or injection site reactions. Severe reactions are rare but possible.

Use during pregnancy should be determined by a healthcare provider based on individual medical needs and risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii, Human Von Willebrand Factor

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT